Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
about
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expressionNonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisTherapeutic uses of non-steroidal anti-inflammatory drugs in dentistryAcute renal failure in an elderly woman following intramuscular ketorolac administrationClinical experience with ketorolac in children.Entrapment of ketorolac tromethamine in polymeric vehicle for controlled drug deliveryThe effects of paracetamol, ketorolac, and paracetamol plus morphine on pain control after thyroidectomyA pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects.A protocol to improve analgesia use in the accident and emergency department.Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.Ketorolac tromethamine formulations: an overview.The efficacy of intravenous ketorolac for pain relief in single-stage adjustable strabismus surgery: a prospective, randomized, placebo-controlled trial.Anaphylactoid reaction following ketorolac tromethamine administration.Recommendations of the national football league physician society task force on the use of toradol(®) ketorolac in the national football leagueIncreased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.Is it safe to use topical NSAIDs for corneal sensitivity in Sjögren's syndrome patients?Effect of ketorolac on the prevention of emergence agitation in children after sevoflurane anesthesiaEvaluation of alternative strategies to optimize ketorolac transdermal delivery.Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.Intranasal ketorolac as part of a multimodal approach to postoperative pain.Prodrug strategies for enhancing the percutaneous absorption of drugs.Role of drug exposure in aphthous ulcers: a case-control study.Effects on growth of human osteoblast-like cells of three nonsteroidal anti-inflammatory drugs: metamizole, dexketoprofen, and ketorolac.Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy.A randomized, double-blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars.Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.Effect of pretreatment with ketorolac tromethamine on operative pain during periodontal surgery: A case-control study.A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs.Optimization of In - vitro Permeation Pattern of Ketorolac Tromethamine Transdermal Patches.Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation.Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses.Prilocaine reduces injection pain caused by propofol.Acute kidney injury in octogenarians after heart valve replacement surgery: a study of two periods over the last decade.Ketorolac (Toradol): a marketing phenomenonEnhancement of ketorolac tromethamine permeability through rat skin using penetration enhancers: An ex-vivo study.Formulation and in Vitro, ex Vivo and in Vivo Evaluation of Elastic Liposomes for Transdermal Delivery of Ketorolac TromethaminePostoperative pain control for dental and oral surgery.Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety.Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
P2860
Q24536398-05308930-CB91-4708-9337-2078F1A9E534Q24646764-39033708-D1DB-4837-B3A4-156C528059CDQ28190316-E073A5DE-6076-4C53-BA3C-893667CB60AFQ28317099-5355D18F-4860-4884-8D6C-D3EC292A1F47Q30465182-9B00E5C9-C9D8-413E-90C1-92211E43B52CQ33757155-6285F1E4-DC6A-4EA3-A592-37DD0BB1EEA4Q33915681-19671BC3-1CC7-42F1-94EC-0920F02FB84EQ34093380-5DCDE06C-19A8-4DCA-9B10-AFD7044768E6Q34291600-C34360AC-EA3B-4C7B-B98D-3FC5FA1EF789Q34806191-7C231743-3F4E-4B92-A214-FCA4DF764872Q34996181-12C5CA31-2D7D-4FE8-93E8-AFFCFFD69C15Q35203041-C850ED17-BD7D-42B9-AF1E-D794371C4571Q35466379-AA423F2E-FFAE-4AF2-A433-5C16EEEAE0D8Q36215174-A7B1D41A-359B-49AE-98CE-99CE7F70890DQ36255870-066433D2-9715-4EB9-A94D-538436C04E4BQ36689062-D6A734A4-8DE9-4650-8633-E1748C99ADD8Q36725403-FF637173-0B5D-49B6-BF7A-A28897368992Q37360791-8A887978-342D-451F-9BD4-3B4E24C9C371Q37638416-AB94C50B-E3DB-4A5D-BA8E-996EF7D2B16CQ38244417-10E30906-FFBF-43E1-816A-DF2FB1F32B2EQ38290414-7E4534B1-B883-4FEE-A03A-CD4A5EE10827Q38917356-451A0539-AC60-4020-94E7-16A1151C40EEQ38941481-5417D2FA-686F-466A-A8E3-5F602E1B3C27Q39257669-AEE68631-EBB1-40CF-82A7-1A67F2A4FBB0Q39474425-BF88F0A4-B199-4952-B79D-B57CD3DB7D77Q39926107-EE64D69A-704B-4E59-8D1F-FD7365824674Q41149976-196C28AC-5D34-4F44-9C0C-9AAF6030E403Q41769318-32220474-CD66-40B9-A32D-C0FCDC3EFA11Q41823588-C74971CD-9A17-435A-B02B-1AA9ED0422DDQ41967727-B8AC3277-C183-432E-B09E-63C54CC61DCCQ41989429-DAD28BED-0195-45B4-8F23-6DB8F2B843F8Q42044837-E1B57F90-A555-4084-9CDC-80C549A03950Q42279808-E6FF2D0C-E259-4046-A094-7A40A0914814Q42368354-7696DB79-F6E9-4377-AB18-70046A9C653CQ42387489-835B4020-CC3C-4862-9A3E-8ACC936F48BDQ42411607-44F60594-D680-452E-9B45-92544BA431DFQ42830830-B54BD230-1183-4825-9347-AF7D55E4E889Q42856328-29BDA5E2-FBA3-4E5E-BC8C-5B517F4B4CAAQ42932547-8C6CDF8D-0997-43E4-9031-D08F9B7C02CDQ45000999-B69BCF18-2D4C-44A4-B909-A8992C69BBAD
P2860
Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@en
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@nl
type
label
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@en
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@nl
prefLabel
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@en
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@nl
P1433
P1476
Ketorolac. A review of its pha ...... es, and therapeutic potential.
@en
P2093
Buckley MM
P304
P356
10.2165/00003495-199039010-00008
P577
1990-01-01T00:00:00Z
P6179
1049188106